Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
The present study has evaluated the protection conferred by a single subcutaneous dose of a modified vaccinia virus Ankara (MVA) vectored vaccine encoding the Rift Valley Fever virus (RVFV) glycoproteins Gn and Gc in lambs. Three groups of six to seven lambs were immunized as follows: one group rece...
Автори: | Busquets, N, Lorenzo, G, López-Gil, E, Rivas, R, Solanes, D, Galindo-Cardiel, I, Abad, F, Rodríguez, F, Bensaid, A, Warimwe, G, Gilbert, S, Domingo, M, Brun, A |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Elsevier
2014
|
Схожі ресурси
Схожі ресурси
-
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
за авторством: Busquets, N, та інші
Опубліковано: (2014) -
Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
за авторством: Busquets, N, та інші
Опубліковано: (2011) -
Rift Valley fever: biology and epidemiology
за авторством: Wright, D, та інші
Опубліковано: (2019) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
за авторством: Warimwe, G, та інші
Опубліковано: (2013) -
MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
за авторством: Elena López-Gil, та інші
Опубліковано: (2020-02-01)